Trials / Unknown
UnknownNCT05336669
Coagulation Profile in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention
Coagulation Profile in Patients Undergoing Coronary Intervention Measured With Activated Clotting Time, Global Thrombosis Test and Platelet Inhibition VerifyNow P2Y12 Test
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Centre of Postgraduate Medical Education · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The activated clotting time (ACT), global thrombosis test (GTT-3), platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography (CA) and percutaneous coronary intervention (PCI).
Detailed description
The activated clotting time (ACT), global thrombosis test (GTT-3) and platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography (CA) and percutaneous coronary intervention (PCI) - 20 smoking and 20 non-smoking.The measurements will take place: before coronary angiography (CA), 10 minutes after unfractionated heparin (HNF), 2h after CA, 6h after CA, 30 days after CA
Conditions
Timeline
- Start date
- 2022-04-30
- Primary completion
- 2022-08-31
- Completion
- 2023-08-31
- First posted
- 2022-04-20
- Last updated
- 2022-04-20
Source: ClinicalTrials.gov record NCT05336669. Inclusion in this directory is not an endorsement.